Vertex cystic fibrosis drugs shown to boost lung function, shrs rise

(Reuters) - Vertex Pharmaceuticals Inc on Thursday said a combination of its cystic fibrosis drug Kalydeco with an experimental compound was shown to improve lung function in a mid-stage trial, and its shares rose 10 percent after the news. The study found that treatment with both drugs for 28 days resulted in a 4.6 percentage point improvement in mean lung function for patients with two specific genetic mutations. ... via Health News Headlines - Yahoo News Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/1hipuP8